期刊文献+

舍曲林治疗少年期强迫症的临床对照研究

A comparative study of Sertraline and Clomipramine in the treatment of Child obsessive-compulsive disorder
下载PDF
导出
摘要 目的:比较舍曲林与氯丙咪嗪治疗少年强迫症的临床疗效及不良反应。方法:将61例少年强迫症随机分为氯丙咪嗪组和舍曲林组,疗程均为8周。分别于入组前、服药2、4、8周末应用Yale-Brown强迫量表(Y-BOCS),汉密尔顿抑郁量表(HAMD),汉密尔顿焦虑量表(HAMA)评定疗效,采用副反应量表(TESS)评定不良反应。结果:舍曲林组和氯丙咪嗪组治疗后,Y-BOCS、HAMD、HAMA分值均显著下降,差异无显著性。舍曲林组不良反应发生率明显少于氯丙咪嗪组。结论:舍曲林治疗少年强迫症与氯丙咪嗪疗效相当,不良反应较轻。 Objective:To compare the efficacy and side effects of sertraline and clomipramine in the treatment of child obsessive-compulsive disorders.Methods:A total of 61 patients were randomly assigned to two groups.One group were treated with sertraline and the other with clomipramine for 8 weeks.The efficacy was measured with Y-BOCS 、HAMD and HAMA.The side effects were assessed by TESS.Results: There was no significant difference in the efficacy between sertraline and clomipramine.The side effects of sertraline were lower than those of clomipramine.Conclusions: Sertrline is effective and safe drug in the treatment of child obsessive-complusive disorders.
出处 《中国民康医学》 2008年第23期2757-2757,2797,共2页 Medical Journal of Chinese People’s Health
关键词 氯丙咪嗪 舍曲林 少年强迫症 Sertraline Clomipramine Child obsessive-compulsive disorder
  • 相关文献

参考文献3

二级参考文献22

  • 1[1]Kessler RC, et al. Lifetime and 12-month prevalence of DSM-Ⅲ-R psychiatric disorders in the United States. Results from the national comorbidity study. Arch Gen Psychiatry, 1994, 51 : 8 ~ 19
  • 2[2]Samuels J, Nestadt G. Epidemiology and genetics of obsessive-compulsive disorder. Int Res Psychiatry, 1997, 9: 61 ~71
  • 3[3]Leckman JF, Zhang HP, Alsobrook JP, et al. Symptom dimensions in obsessive-compulsive disorder: toward quantitative phenotypes. Am J Med Genet, 2001, 105 : 28 ~ 30
  • 4[4]Karno M, Golding JM, Obsessive-compulsive disorder. In Robins LN, Regier DA(eds): Psychiatric disorders in American. the epidemiologic cathment area study. New York. The Free Press, 1991,204 ~219
  • 5[5]Meltzer H, Gill B, Petticrew M, et al. OPCS surveys of psychiatric morbidity in Great Britain. Report No 1. The prevalence of psychiatric morbidity among adults living private Households Londond: office of population censuses and surveys, 1995
  • 6[6]Jenkins R, Bebbinbgton PE, Brugha T, et al. The national psychiatric morbidity surveys of Great Britain: Strategy and methods. Psycho logical Medicine, 1997, 27 : 765 ~774
  • 7[8]Jonnal AH, Gardner CO, Prescott CA, et al. Obsessive and compulsive synptoms in a general population sample of female twins. Am JMed Genet, 2000, 96: 791 ~796
  • 8[9]Hettema JM, Neale MC, Kendler KS. A review and meta-anxiety disorders. Am J Psychiatry, 2001, 158(10) : 1568 ~1578
  • 9[10]Crum RM, Authony JC. Cocaine use and other suspected risk factors for obsessive-compulsive disorder: a prospective study with data from the epidemiologic catchment area study. Drug Alcohol Depend,1993, 31 : 281 ~295
  • 10[11]Eisen JL, Goodman WK, Keller MB, et al. Patterns of remission relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry, 1999, 60:346~351

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部